No photo of Aaron LeBeau
Contact Expert

View Scopus Profile

Aaron LeBeau

20052024
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 2 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Molecular Imaging Medicine & Life Sciences
Peptide Hydrolases Medicine & Life Sciences
Peptides Medicine & Life Sciences
Urokinase Plasminogen Activator Receptors Medicine & Life Sciences
Urokinase-Type Plasminogen Activator Medicine & Life Sciences
Heterografts Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2024

Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer

LeBeau, A. & Li, F.

NIH NATIONAL CANCER INSTITUTE (NCI)

1/1/20 → 12/31/24

Project: Research project

Cyclic Peptides
Protease Inhibitors
Prostatic Neoplasms

Function and Clinical Utility of the HOXB13 Co-Factors MEIS1 and MEIS2 in Prostate Cancer Progression

LeBeau, A.

UNIV OF ILLINOIS CHICAGO

1/1/20 → 12/31/20

Project: Research project

Prostatic Neoplasms

CD133-Targeted Natural Killer Cell Therapy for Aggressive Prostate Cancer

LeBeau, A. & Moriarity, B. S.

U.S. DEPARTMENT OF DEFENSE

8/1/19 → 7/31/22

Project: Research project

Cell- and Tissue-Based Therapy
Natural Killer Cells
Prostatic Neoplasms

Novel Radioimmunotherapy Strategies for Prostate Cancer

LeBeau, A. & Murugan, P.

NIH NATIONAL CANCER INSTITUTE (NCI)

7/1/19 → 6/30/24

Project: Research project

Radioimmunotherapy
Prostatic Neoplasms

Targeting CD133 for imaging and therapy in prostate cancer

LeBeau, A., Jallow, N. & Murugan, P.

NIH NATIONAL CANCER INSTITUTE (NCI)

7/1/19 → 6/30/24

Project: Research project

Prostatic Neoplasms
Therapeutics

Research Output 2005 2019

Correction: Exploiting the transcriptional specificity of the alphamethylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer (Oncotarget (2018) 9 (36693-36704) DOI: 10.18632/oncotarget.26401)

Shapovalova, M., Davydova, J., Henzler, C., Daniel, M., Dehm, S. M., Warlick, C. A. & LeBeau, A. M., Aug 1 2019, In : Oncotarget. 10, 47, 1 p.

Research output: Contribution to journal › Comment/debate

Open Access
Racemases and Epimerases
Molecular Imaging
Coenzyme A
Prostatic Neoplasms
Research

Development of a cross-reactive monoclonal antibody for detecting the tumor stroma

Hintz, H. M., Cowan, A. E., Shapovalova, M. & LeBeau, A., May 15 2019, In : Bioconjugate Chemistry. 30, 5, p. 1466-1476 11 p.

Research output: Contribution to journal › Article

Monoclonal antibodies
Fibroblasts
Tumors
Immunoglobulin G
Monoclonal Antibodies

PEG10 promoter-driven expression of reporter genes enables molecular imaging of lethal prostate cancer

Shapovalova, M., Lee, J. K., Li, Y., Griend, D. J. V., Coleman, I. M., Nelson, P. S., Dehm, S. M. & LeBeau, A. M., Nov 1 2019, In : Cancer Research. 79, 21, p. 5668-5680 13 p.

Research output: Contribution to journal › Article

Molecular Imaging
Reporter Genes
Prostatic Neoplasms
Androgen Receptors
Genes
2 Citations (Scopus)

The identification of a novel antibody for CD133 using human antibody phage display

Glumac, P. M., Forster, C. L., Zhou, H., Murugan, P., Gupta, S. & LeBeau, A., Sep 15 2018, In : Prostate. 78, 13, p. 981-991 11 p.

Research output: Contribution to journal › Article

Bacteriophages
Antibodies
Immunohistochemistry
Prostate
Single-Chain Antibodies
1 Citation (Scopus)

The Molecular Imaging of Natural Killer Cells

Shapovalova, M., Pyper, S. R., Moriarity, B. S. & LeBeau, A., Sep 8 2018, In : Molecular imaging. 17

Research output: Contribution to journal › Review article

Molecular Imaging
Natural Killer Cells
Cell- and Tissue-Based Therapy
Immunotherapy
Antibody-Dependent Cell Cytotoxicity